Ayyakkannu Ayyanan (Ayyakkannu Ayyannan)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum

Extracellular Matrix

Cell Proliferation

Top Venues

EMBO molecular medicine

NPJ breast cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Johan Staaf, Jari Häkkinen, Cecilia Hegardt, Lao H Saal, Siker Kimbung, Ingrid Hedenfalk, Tonje Lien, Therese Sørlie, Bjørn Naume, Hege Russnes, Rachel Marcone, Ayyakkannu Ayyanan, Cathrin Brisken, Rebecka R Malterling, Bengt Asking, Helena Olofsson, Henrik Lindman, Pär-Ola Bendahl, Anna Ehinger, Christer Larsson, Niklas Loman, Lisa Rydén, Martin Malmberg, Åke Borg, Johan Vallon-Christersson
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ breast cancer 8 (1) (2022)
Valentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino, Andrea Agnoletto, Laura Battista, Csaba Laszlo, Assia Treboux, Khalil Zaman, Athina Stravodimou, Didier Jallut, Maryse Fiche, Philipp Bucher, Giovanna Ambrosini, George Sflomos, Cathrin Brisken
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor. Nature communications 13 (1) (2022)
Marie Shamseddin, Fabio De Martino, Céline Constantin, Valentina Scabia, Anne-Sophie Lancelot, Csaba Laszlo, Ayyakkannu Ayyanan, Laura Battista, Wassim Raffoul, Marie-Christine Gailloud-Matthieu, Philipp Bucher, Maryse Fiche, Giovanna Ambrosini, George Sflomos, Cathrin Brisken
Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation. EMBO molecular medicine 13 (7) (2021)
George Sflomos, Laura Battista, Patrick Aouad, Fabio De Martino, Valentina Scabia, Athina Stravodimou, Ayyakkannu Ayyanan, Assia Ifticene-Treboux, null null, Philipp Bucher, Maryse Fiche, Giovanna Ambrosini, Cathrin Brisken
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1. EMBO molecular medicine 13 (3) (2021)